Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

FiscalNote Holdings (NOTE) Research & Development (2021 - 2026)

FiscalNote Holdings has reported Research & Development over the past 6 years, most recently at $2.0 million for Q1 2026.

  • For Q1 2026, Research & Development fell 34.19% year-over-year to $2.0 million; the TTM value through Mar 2026 reached $8.5 million, down 31.65%, while the annual FY2025 figure was $9.6 million, 25.39% down from the prior year.
  • Research & Development for Q1 2026 was $2.0 million at FiscalNote Holdings, down from $2.1 million in the prior quarter.
  • Over five years, Research & Development peaked at $6.0 million in Q1 2022 and troughed at $2.0 million in Q1 2026.
  • A 5-year average of $3.7 million and a median of $3.5 million in 2024 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: rose 18.97% in 2023 and later tumbled 35.97% in 2025.
  • Year by year, Research & Development stood at $5.3 million in 2022, then decreased by 24.2% to $4.0 million in 2023, then fell by 27.96% to $2.9 million in 2024, then dropped by 26.72% to $2.1 million in 2025, then fell by 3.68% to $2.0 million in 2026.
  • Business Quant data shows Research & Development for NOTE at $2.0 million in Q1 2026, $2.1 million in Q4 2025, and $2.1 million in Q3 2025.